You just read:

TAKHZYRO® (lanadelumab injection) receives positive recommendation from CADTH's Canadian Drug Expert Committee (CDEC) for the routine prevention of hereditary angioedema (HAE) attacks

News provided by

Takeda Canada

Nov 22, 2019, 14:45 ET